Enhancement of intermediate-term memory by an alpha-1 agonist or a partial agonist at the glycine site of the NMDA receptor - PubMed (original) (raw)

Enhancement of intermediate-term memory by an alpha-1 agonist or a partial agonist at the glycine site of the NMDA receptor

R Pussinen et al. Neurobiol Learn Mem. 1997 Jan.

Abstract

The aim of the present study was to investigate whether the activation of alpha-1 adrenergic receptors can influence intermediate-term memory. Therefore, the effects of ST 587 (30 or 100 micrograms/kg), a putative alpha-1 agonist, on the retention of the radial arm task using non-matching to sample with a 4-h delay were investigated in rats. The results indicated that the administration of ST 587 (100 micrograms/kg) before a sampling phase increased the time to complete the sampling phase which was due to an increased number of errors of repetition (regarded as working memory errors) and a reduced number of arms visited in a given time (regarded as behavioral activity). However, this treatment increased the number of correct choices before the first error during the retention phase in this task. Since we were also interested in investigating the role of NMDA receptors in memory encoding, we investigated whether NMDA receptor modulation by d-cycloserine (1 or 10 mg/kg), a partial agonist of the glycine site on the NMDA receptor, had any influence on the performance of rats in this task. The results indicated that d-cycloserine (10 mg/kg) given before the sampling phase did not influence the performance of rats during the sampling phase, but it did improve their choice accuracy during the retention phase of this task. These data suggest that the systemic administration of either an alpha-1 agonist or an indirect agonist of NMDA receptors can facilitate intermediate-term retention of spatial information.

PubMed Disclaimer

Cited by

A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus.
Zhang XL, Sullivan JA, Moskal JR, Stanton PK. Zhang XL, et al. Neuropharmacology. 2008 Dec;55(7):1238-50. doi: 10.1016/j.neuropharm.2008.08.018. Epub 2008 Aug 29. Neuropharmacology. 2008. PMID: 18796308 Free PMC article.
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.
Walker DL, Ressler KJ, Lu KT, Davis M. Walker DL, et al. J Neurosci. 2002 Mar 15;22(6):2343-51. doi: 10.1523/JNEUROSCI.22-06-02343.2002. J Neurosci. 2002. PMID: 11896173 Free PMC article.
Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches.
Sartori SB, Maurer V, Murphy C, Schmuckermair C, Muigg P, Neumann ID, Whittle N, Singewald N. Sartori SB, et al. Int J Neuropsychopharmacol. 2016 Jun 1;19(6):pyv128. doi: 10.1093/ijnp/pyv128. Print 2016 Jun. Int J Neuropsychopharmacol. 2016. PMID: 26625894 Free PMC article.
Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning.
Todd TP, Vurbic D, Bouton ME. Todd TP, et al. Neurobiol Learn Mem. 2014 Feb;108:52-64. doi: 10.1016/j.nlm.2013.08.012. Epub 2013 Aug 30. Neurobiol Learn Mem. 2014. PMID: 23999219 Free PMC article. Review.
Alpha1-Adrenergic Receptor Mediated Long-Term Depression at CA3-CA1 Synapses Can Be Induced via Accumulation of Endogenous Norepinephrine and Is Preserved Following Noradrenergic Denervation.
Dyer-Reaves K, Goodman AM, Nelson AR, McMahon LL. Dyer-Reaves K, et al. Front Synaptic Neurosci. 2019 Oct 9;11:27. doi: 10.3389/fnsyn.2019.00027. eCollection 2019. Front Synaptic Neurosci. 2019. PMID: 31649525 Free PMC article.

Enhancement of intermediate-term memory by an alpha-1 agonist or a partial agonist at the glycine site of the NMDA receptor - PubMed (original) (raw)